Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,467
Total Claims
$1.7M
Drug Cost
490
Beneficiaries
$3,454
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+145%
Cost per patient vs peers
$3,454 vs $1,411 avg
+36%
Brand preference vs peers
14.5% vs 10.6% avg
Brand vs Generic
Brand: 2,055 claims · $1.4M
Generic: 12,147 claims · $290K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 388 | $324K |
| Icosapent Ethyl | 480 | $248K |
| Empagliflozin | 187 | $160K |
| Icosapent Ethyl | 229 | $90K |
| Tenofovir Alafenamide | 52 | $78K |
| Diclofenac Epolamine | 95 | $77K |
| Linagliptin | 97 | $75K |
| Dapagliflozin Propanediol | 67 | $67K |
| Apixaban | 88 | $62K |
| Diclofenac Sodium | 20 | $53K |
| Insulin Aspart Prot/Insuln Asp | 29 | $33K |
| Insulin Lispro Protamin/Lispro | 25 | $27K |
| Rivaroxaban | 24 | $23K |
| Losartan Potassium | 1,488 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 38 | $18K |
Prescribing Profile
Patient Profile
73
Avg Age
49%
Female
1.00
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data